Peptide record

TPDB45070

Antiviral standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45070
Antiviral
Anti-infective peptides
AVPpred-BWR
standard
No
A 16-aa standard-residue antiviral peptide sequence curated from AVPpred-BWR, with an available 3D structural model.
Sequence
CATCADSQHRSHRQMV
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C70H116N28O24S3
NEGILKFPWY
ARCQHS
1830.04
8.30
4
1
4
+1
3.48
-0.844
30.63
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
125
0.07
7
Residue Composition
number
2
A
2
R
0
N
1
D
2
C
0
E
2
Q
0
G
2
H
0
I
0
L
0
K
1
M
0
F
0
P
2
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 2 N: 0 D: 1 C: 2 E: 0 Q: 2 G: 0 H: 2 I: 0 L: 0 K: 0 M: 1 F: 0 P: 0 S: 2 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
16 reviewed residue count
C70H116N28O24S3 sequence-only estimate (linear, free termini)
1830.04 sequence-only estimate (linear, free termini)
8.30 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
3.48 sequence-only estimate (linear, free termini)
-0.844 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA